HLN: Haleon plc
Performance
Watchlist
Select an item
Summary
HLN at a glance
HLN returned -3.26% over the past year. Its worst drop in that year was -22.42%, smaller than 75% of stocks on Redstone, and its Sharpe ratio of -0.11 beats 23% of stocks on Redstone. It yields 2.21%.
Current Drawdown
-18.80%
Rolling Volatility
56.98%
Dividends
HLN dividends
Yield
2.21%
Paid, past year
$0.20
Pays
Twice a year
Growth a year
-5.7%
Per share, by year
Return over the past year
HLN paid $0.20 a share over the past year, twice a year. Its yearly rate fell from $0.10 in 2023 to $0.09 in 2025, 5.7% a year. With dividends reinvested it returned -3.26% over the past year, against -5.18% on price alone.
›All 8 payments since Mar 16, 2023
- Aug 14, 2026$0.0647
- Apr 10, 2026$0.1333
- Aug 15, 2025$0.0598
- Apr 25, 2025$0.1246
- Aug 16, 2024$0.0527
- Mar 14, 2024$0.1053
- Aug 24, 2023$0.0439
- Mar 16, 2023$0.0597
Metrics
Risk Indicators
Profile
About HLN
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022.
- Sector
- Consumer Staples
- Market cap
- $39.4B
- Listed
- Jul 2022
- Employees
- 24,524
- Website
- haleon.com
Comparisons